In addition the service person is to be interviewed to discuss any health concerns and potential health risks are to be communicated clearly. All persons who have considerable concerns, regardless of assessed degree of exposure, need to be considered for screening to assist in alleviating such concerns. Blood urea, and serum electrolytes. Medical officers are to follow-up abnormal results in the context of all possible causes for the abnormality. Because of the low likelihood of adverse health directly related to DU it would be a diagnosis of careful exclusion substantiated by appropriate specialist opinion.
Further testing is to be carried out as clinically indicated.
Follow-up screening is to be repeated as part of the routine interval for medical boards on the MD915 or MD914 format. If abnormal results are obtained the frequency of medical checks will need to be appropriately adjusted. No medical treatment facilities or individual medical officers are to initiate alternative screening. Additional material that will assist in providing accurate information on DU will be found on the Medical Intranet site.